The neurocognitive assessment and rehabilitation market has seen considerable growth due to a variety of factors.
• The neurocognitive assessment and rehabilitation market has shown strong growth in recent years. It will rise from $13.4 billion in 2024 to $14.7 billion in 2025, at a CAGR of 9.7%.
This growth is due to the increasing incidence of neurocognitive disorders, an aging population, greater awareness, and improvements in diagnostic techniques.
The neurocognitive assessment and rehabilitation market is expected to maintain its strong growth trajectory in upcoming years.
• The neurocognitive assessment and rehabilitation market is forecast to reach $21 billion by 2029 at a CAGR of 9.3%.
Growth is attributed to personalized medicine, corporate wellness programs, and advancements in technology. Key trends include the adoption of wearable technologies, neuroplasticity research, and the use of VR/AR in rehabilitation programs.
The rising prevalence of neurological disorders is also expected to fuel the growth of the neurocognitive assessment and rehabilitation market. Neurological disorders can cause cognitive impairments, weakness, and coordination issues. As the global population ages, the incidence of conditions like Alzheimer's and Parkinson's diseases is rising. Neurocognitive assessments help in diagnosing and managing these disorders, while rehabilitation interventions aim to optimize cognitive function and quality of life. For instance, the Alzheimer's Association projected that the number of individuals with Alzheimer's dementia in the U.S. aged 85 and older will increase from 2.4 million in 2024 to 6.7 million by 2060, driving the growth of this market.
The neurocognitive assessment and rehabilitation market covered in this report is segmented –
1) By Components: Neurocognitive Assessment Testing, Neurorehabilitation Therapy
2) By Providers: Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers
3) By Organization Size: Large Enterprises, Small And Medium-sized Enterprises (SMEs)
Subsegments:
1) By Neurocognitive Assessment Testing: Standardized Tests, Computerized Neurocognitive Assessments, Paper-Based Neurocognitive Tests
2) By Neurorehabilitation Therapy: Cognitive Behavioral Therapy (CBT), Virtual Reality Therapy, Transcranial Magnetic Stimulation (TMS), Neurofeedback Therapy, Physical Therapy And Occupational Therapy
Leading businesses in the neurocognitive assessment and rehabilitation market are pioneering novel solutions like digital tests, which are designed to evaluate cognitive impairments and offer a competitive advantage. Digital tests entail the use of digital platforms or software to assess different cognitive abilities including memory, attention, language, and executive function. For instance, Neurotrack Technologies, a company based in the US that offers online screening tools and cognitive health programs, rolled out a 3-minute digital test for cognitive impairment screening in November 2022. This tool allows primary care teams to rapidly conduct cognitive decline screenings during annual wellness visits, contributing to the early identification of neurodegenerative diseases like Alzheimer's. It possesses culturally-neutral features that boost precision and accessibility, catering to the urgent requirement for cognitive screening as the population ages. This groundbreaking solution allows healthcare providers to effortlessly incorporate cognitive testing into clinical routines, and is likely to transform dementia care and intervention methods.
Major companies operating in the neurocognitive assessment and rehabilitation market are:
• Cogstate Ltd.
• Posit Science Corporation
• Lumos Labs Inc.
• The Magstim Company Ltd.
• MindMaze SA
• CogniFit Inc.
• Cambridge Cognition Holdings plc
• ImPACT Applications Inc.
• Neurotrack Technologies Inc.
• Neuroelectrics Corporation
• SCHUHFRIED GmbH
• Constant Therapy Health Inc.
• NeuronUP S.L.
• Qbtech AB
• Neurometrix Inc.
• CogniVue Corporation
• Neurohealth Associates LLP
• BrainTrain Inc.
• NeuroEM Therapeutics Inc.
• HASOMED GmbH
• Neurosoft Bioelectronics Corporation
• AnthroTronix Inc.
• Flow Neuroscience AB
• NPsych Limited
North America was the largest region in the neurocognitive assessment and rehabilitation market in 2024. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.